211 related articles for article (PubMed ID: 22529993)
1. Propylthiouracil is teratogenic in murine embryos.
Benavides VC; Mallela MK; Booth CJ; Wendler CC; Rivkees SA
PLoS One; 2012; 7(4):e35213. PubMed ID: 22529993
[TBL] [Abstract][Full Text] [Related]
2. Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos.
van Veenendaal NR; Ulmer B; Boskovski MT; Fang X; Khokha MK; Wendler CC; Blum M; Rivkees SA
FASEB J; 2013 Feb; 27(2):684-91. PubMed ID: 23150524
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of developmental toxicity of propylthiouracil and methimazole.
Mallela MK; Strobl M; Poulsen RR; Wendler CC; Booth CJ; Rivkees SA
Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):300-7. PubMed ID: 24980470
[TBL] [Abstract][Full Text] [Related]
4. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
5. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
6. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.
Andersen SL; Lönn S; Vestergaard P; Törring O
Eur J Endocrinol; 2017 Oct; 177(4):369-378. PubMed ID: 28780518
[TBL] [Abstract][Full Text] [Related]
7. Toxicological considerations for antithyroid drugs in children.
Karras S; Tzotzas T; Krassas GE
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
[TBL] [Abstract][Full Text] [Related]
10. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
[TBL] [Abstract][Full Text] [Related]
12. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
13. Teratogen update: Antithyroid medications.
Romeo AN; Običan SG
Birth Defects Res; 2020 Sep; 112(15):1150-1170. PubMed ID: 32738035
[TBL] [Abstract][Full Text] [Related]
14. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
Abuid J; Larsen PR
J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
Nagayama Y; Eishima K; Hirayu H; Yamashita S; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Morita S; Izumi M
Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes.
Yoshihara A; Luo Y; Ishido Y; Usukura K; Oda K; Sue M; Kawashima A; Hiroi N; Suzuki K
Endocr J; 2019 Apr; 66(4):349-357. PubMed ID: 30814441
[TBL] [Abstract][Full Text] [Related]
18. Exacerbated liver injury of antithyroid drugs in endotoxin-treated mice.
Heidari R; Ahmadi F; Rahimi HR; Azarpira N; Hosseinzadeh M; Najibi A; Niknahad H
Drug Chem Toxicol; 2019 Nov; 42(6):615-623. PubMed ID: 29722569
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
Liu Y; Li Q; Xu Y; Chen Y; Men Y
PLoS One; 2023; 18(5):e0286097. PubMed ID: 37205692
[TBL] [Abstract][Full Text] [Related]
20. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
Morales DR; Fonkwen L; Nordeng HME
Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
